BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18544639)

  • 1. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.
    Johnson KA; Rose DM; Terkeltaub RA
    J Cell Sci; 2008 Jul; 121(Pt 13):2256-64. PubMed ID: 18544639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
    Johnson KA; Terkeltaub RA
    J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
    Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
    J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
    Merz D; Liu R; Johnson K; Terkeltaub R
    J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
    Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
    Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.
    Cecil DL; Terkeltaub R
    J Immunol; 2008 Jun; 180(12):8378-85. PubMed ID: 18523305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
    Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.
    Huebner JL; Johnson KA; Kraus VB; Terkeltaub RA
    Osteoarthritis Cartilage; 2009 Aug; 17(8):1056-64. PubMed ID: 19328881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.
    Tarantino U; Oliva F; Taurisano G; Orlandi A; Pietroni V; Candi E; Melino G; Maffulli N
    Amino Acids; 2009 Apr; 36(4):679-84. PubMed ID: 18594942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
    Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
    Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis.
    Nurminsky D; Shanmugasundaram S; Deasey S; Michaud C; Allen S; Hendig D; Dastjerdi A; Francis-West P; Nurminskaya M
    Mech Dev; 2011; 128(3-4):234-45. PubMed ID: 21129482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.
    Adamczyk M
    Amino Acids; 2017 Mar; 49(3):625-633. PubMed ID: 27510997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.
    Hoffmann BR; Annis DS; Mosher DF
    J Biol Chem; 2011 Sep; 286(37):32220-30. PubMed ID: 21757696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological analysis of transglutaminase factor XIIIA expression in mouse embryonic growth plate.
    Nurminskaya MV; Linsenmayer TF
    J Orthop Res; 2002 May; 20(3):575-8. PubMed ID: 12038633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ1-Induced Transglutaminase-2 Triggers Catabolic Response in Osteoarthritic Chondrocytes by Modulating MMP-13.
    Park JY; Bae HC; Pyo SH; Lee MC; Han HS
    Tissue Eng Regen Med; 2021 Oct; 18(5):831-840. PubMed ID: 34014552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-Regulation of Transglutaminase 2 Stimulates Redifferentiation of Dedifferentiated Chondrocytes through Enhancing Glucose Metabolism.
    Ko KW; Choi B; Park S; Arai Y; Choi WC; Lee JM; Bae H; Han IB; Lee SH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
    Rosenthal AK; Mosesson MW; Gohr CM; Masuda I; Heinkel D; Seibenlist KR
    Thromb Haemost; 2004 Mar; 91(3):558-68. PubMed ID: 14983233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase factor XIIIA in the cartilage of developing avian long bones.
    Nurminskaya MV; Recheis B; Nimpf J; Magee C; Linsenmayer TF
    Dev Dyn; 2002 Jan; 223(1):24-32. PubMed ID: 11803567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
    Johnson KA; Polewski M; Terkeltaub RA
    Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.
    Al-Jallad HF; Myneni VD; Piercy-Kotb SA; Chabot N; Mulani A; Keillor JW; Kaartinen MT
    PLoS One; 2011 Jan; 6(1):e15893. PubMed ID: 21283799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.